Cargando…
培美曲塞治疗全身化疗和吉非替尼治疗失败的肺腺癌32例临床观察
BACKGROUND AND OBJECTIVE: The relapse-free time of gefitinib as the second or third line therapy in patients with advanced non-small cell lung cancer (NSCLC) was not satisfactory. The aim of this study is to evaluate the efficacy and toxicity of pemetrexed in patients with pulmonary adenocarcinoma a...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000551/ https://www.ncbi.nlm.nih.gov/pubmed/20704823 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.08.11 |